Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 19

1.

[11C]GR103545: novel one-pot radiosynthesis with high specific activity.

Nabulsi NB, Zheng MQ, Ropchan J, Labaree D, Ding YS, Blumberg L, Huang Y.

Nucl Med Biol. 2011 Feb;38(2):215-21. doi: 10.1016/j.nucmedbio.2010.08.014. Epub 2010 Dec 3.

PMID:
21315277
2.
3.

Opioids: old drugs for potential new applications.

Barry U, Zuo Z.

Curr Pharm Des. 2005;11(10):1343-50. Review.

PMID:
15853689
4.

11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.

Talbot PS, Narendran R, Butelman ER, Huang Y, Ngo K, Slifstein M, Martinez D, Laruelle M, Hwang DR.

J Nucl Med. 2005 Mar;46(3):484-94.

5.

Opioid receptors.

Waldhoer M, Bartlett SE, Whistler JL.

Annu Rev Biochem. 2004;73:953-90. Review.

PMID:
15189164
6.

[(11)C]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers.

Ravert HT, Scheffel U, Mathews WB, Musachio JL, Dannals RF.

Nucl Med Biol. 2002 Jan;29(1):47-53.

PMID:
11786275
7.

GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys.

Butelman ER, Ko MC, Traynor JR, Vivian JA, Kreek MJ, Woods JH.

J Pharmacol Exp Ther. 2001 Sep;298(3):1049-59.

8.
9.

Interactions between kappa opioid agonists and cocaine. Preclinical studies.

Mello NK, Negus SS.

Ann N Y Acad Sci. 2000;909:104-32. Review.

PMID:
10911926
10.
11.
12.
13.

Dynorphin and the kappa 1 ligand [3H]U69,593 binding in the human epileptogenic hippocampus.

de Lanerolle NC, Williamson A, Meredith C, Kim JH, Tabuteau H, Spencer DD, Brines ML.

Epilepsy Res. 1997 Oct;28(3):189-205.

PMID:
9332884
14.

Laminar distribution of the multiple opioid receptors in the human cerebral cortex.

Hiller JM, Fan LQ.

Neurochem Res. 1996 Nov;21(11):1333-45.

PMID:
8947923
15.

Molecular pharmacology of the opioid receptors.

Satoh M, Minami M.

Pharmacol Ther. 1995;68(3):343-64. Review.

PMID:
8788562
16.

Molecular biology of the opioid receptors: structures, functions and distributions.

Minami M, Satoh M.

Neurosci Res. 1995 Sep;23(2):121-45. Review.

PMID:
8532211
17.

Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: a pilot study.

Chappell PB, Leckman JF, Scahill LD, Hardin MT, Anderson G, Cohen DJ.

Psychiatry Res. 1993 Jun;47(3):267-80.

PMID:
8396784
18.

A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines.

Naylor A, Judd DB, Lloyd JE, Scopes DI, Hayes AG, Birch PJ.

J Med Chem. 1993 Jul 23;36(15):2075-83.

PMID:
8393489
19.

Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.

Birch PJ, Rogers H, Hayes AG, Hayward NJ, Tyers MB, Scopes DI, Naylor A, Judd DB.

Br J Pharmacol. 1991 Jul;103(3):1819-23.

Supplemental Content

Support Center